GEODE CAPITAL MANAGEMENT, LLC - SCOPUS BIOPHARMA INC ownership

Back to all holdings Add to watchlist

SCOPUS BIOPHARMA INC's ticker is SCPS and the CUSIP is 809171101. A total of 29 filers reported holding SCOPUS BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SCOPUS BIOPHARMA INC
ValueSharesWeighting
Q3 2022$52,000
-44.1%
217,0780.0%0.00%–
Q2 2022$93,000
-33.6%
217,078
+6.5%
0.00%–
Q1 2022$140,000
+29.6%
203,805
+208.2%
0.00%–
Q4 2021$108,000
-75.5%
66,121
+26.8%
0.00%–
Q1 2021$440,000–52,159–0.00%–
 Download
Other shareholders
SCOPUS BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
M&R CAPITAL MANAGEMENT INC 76,819$33,0000.01%
VANGUARD GROUP INC 54,649$24,0000.00%
UBS Group AG 100$00.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,966$14,0000.00%
Compagnie Lombard Odier SCmA 4,360$2,0000.00%
FIRST MANHATTAN CO. LLC. 25,800$11,0000.00%
WELLS FARGO & COMPANY/MN 89$00.00%
NORTHERN TRUST CORP 12,516$5,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 217,078$93,0000.00%
View complete list of SCOPUS BIOPHARMA INC shareholders